Prim, S.A. (FRA:5P1)

Market Cap	225.36M +8.6%
Revenue (ttm)	250.65M +4.1%
Net Income	13.03M -10.4%
EPS	0.77 -9.9%
Shares Out	n/a
PE Ratio	17.29
Forward PE	11.37
Dividend	0.43 (3.27%)
Ex-Dividend Date	Jul 13, 2026

Volume	n/a
Open	13.10
Previous Close	13.15
Day's Range	13.10 - 13.10
52-Week Range	11.90 - 14.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 9, 2026

About Prim, S.A.

Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, com...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1870
• Employees: 959
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5P1

Financial Performance

In 2025, Prim, S.A.'s revenue was 251.89 million, an increase of 7.94% compared to the previous year's 233.36 million. Earnings were 16.68 million, an increase of 52.77%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error